fda warning letters compounded glp-1 september 2025 Trends In FY FDA issued 25 warning letters

How much does Restylane Refyne cost

As GLP-1 receptor agonists continue to be widely adopted for obesity and metabolic disease, it is essential to consider their broader implications for bone health and orthopedic surgery

Compounded tirzepatide is a version of the active ingredient in brand-name Zepbound and Mounjaro, prepared by a compounding pharmacy rather than the original manufacturer Eli Lilly

Bariatric surgery, rather than managing ongoing side effects of GLP-1 medications, eliminates the need for these drugs altogether

Food & Drug Administration (FDA) has not approved a generic formulation of semaglutide

After giving bremelanotide by mouth, they reported that the result was minimal absorption